Table 2.
Points distribution of the RETREAT score for the overall cohort, recurrences, and no recurrences.
| Predictor | RETREAT Points |
Overall (n = 203) (%) |
Recurrence (n = 27) (%) | No Recurrence (n = 176) (%) |
|---|---|---|---|---|
| Last AFP pre LT (µg/L) | ||||
| 0–20 | 0 | 160 (78.8) | 15 (55.6) | 145 (82.4) |
| 21–99 | 1 | 19 (9.4) | 1 (3.7) | 18 (10.2) |
| 100–999 | 2 | 19 (9.4) | 7 (25.9) | 12 (6.8) |
| ≥1000 | 3 | 5 (2.5) | 4 (14.8) | 1 (0.6) |
| Microvascular invasion | 2 | 45 (22.2) | 16 (59.3) | 29 (16.5) |
| Largest viable tumor diameter (cm) plus number of viable tumors | ||||
| 0 * | 0 | 40 (19.7) | 0 (0.0) | 40 (22.7) |
| 1.1–4.9 | 1 | 105 (51.7) | 10 (37.0) | 95 (54.0) |
| 5.0–9.9 | 2 | 53 (26.1) | 14 (51.9) | 39 (22.2) |
| ≥10 | 3 | 5 (2.5) | 3 (11.1) | 2 (1.1) |
* No viable tumor on explant pathology. Abbreviations: AFP, α-fetoprotein; LT, liver transplantation.